Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 5 Datasets 392.5k Experiments 4.7k

Explore

Filters: North America ✕ 2023 ✕ microarray-expr ✕ clear all

5 matching publication(s)

Publication	Journal	Year	Score	Verdict
Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling. PMID 37958322	Cancers (Basel)	2023	50	L1 50/100
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. PMID 37563310	Nat Immunol	2023	93	L1 93/100
Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatment. PMID 37471455	PLoS Comput Biol	2023	100	L1 100/100
VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data. PMID 37180100	Front Immunol	2023	64	L1 64/100
Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature. PMID 37076665	NPJ Precis Oncol	2023	50	L1 50/100

Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling.

PMID 37958322 · Cancers (Basel) · 2023

L1 50/100

Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.

PMID 37563310 · Nat Immunol · 2023

L1 93/100

Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatment.

PMID 37471455 · PLoS Comput Biol · 2023

L1 100/100

VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data.

PMID 37180100 · Front Immunol · 2023

L1 64/100

Exploiting convergent phenotypes to derive a pan-cancer cisplatin response gene expression signature.

PMID 37076665 · NPJ Precis Oncol · 2023

L1 50/100